Speakers at a recent White House listening session pleaded with the Biden administration to modernize U.S. regulatory oversight of gene-edited plant products to compete with other countries that have streamlined processes allowing for quicker approval.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.